510(k) Report

510(k) · Cleared

Recalled · Class II · 2024

PVS 1600 Synchro 0.010 Neuro Guide Wire

K023700510(k) SpecialCleared Dec 4, 200230-day reviewClass II21 CFR 870.1330Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Precision Vascular Systems, Inc. · DQX Wire, Guide, Catheter

Cleared on Dec 4, 2002 as substantially equivalent to K002907 (Precision Vascular Systems, Inc., 2001) and 3 other predicates after a 30-day review. Its family tree reaches back 1 generation to 1997. It has been recalled once.

Decided
Dec 4, 2002
Review
30 days
Class
Class II
Product code
DQX
Recalls
1
Predicates
4

Its longest line of descent runs back 1 generation to K964611 (1997). 4 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestor2000: 1 other ancestor1999: 1 other ancestorK964611 · Transend Guidewire · Boston Scientific Corp · 199719961998200020022004
Other ancestors, by generation 1 generation back: 3 other ancestors K964611 · Transend Guidewire · Boston Scientific Corp · 19970
  1. Root · 1 generation backK964611 Transend GuidewireBoston Scientific Corp · 1997
  2. This deviceK023700 PVS 1600 Synchro 0.010 Neuro Guide WirePrecision Vascular Systems, Inc. · 2002
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K964611Transend GuidewireBoston Scientific Corp1997—
0 (this device)K023700PVS 1600 Synchro 0.010 Neuro Guide WirePrecision Vascular Systems, Inc.2002—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
200110
FIG. 1 — Lineage of K023700, 1997–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQX device

  1. #1 K213854 SavvyWirescore 15.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K002907PVS 1300 Neuro Guide Wire
Summary page 1
…Code Predicate 1 Devices SynchroTM .OIY I Precision Vascular I K002907,08 March 2001 I DQX Transend-I 0 1 Target Therapeutics I K964611, 02 May 1996*…
Precision Vascular Systems, Inc.20011
*K964611Transend Guidewire
Summary page 1
…I K002907,08 March 2001 I DQX Transend-I 0 1 Target Therapeutics I K964611, 02 May 1996* I DQX Agility-I 0 I Cordis 1 K991646,20 Jul2000…
Boston Scientific Corp1997—
*K991646Agility Steerable Guidewire
Summary page 1
…Transend-I 0 1 Target Therapeutics I K964611, 02 May 1996* I DQX Agility-I 0 I Cordis 1 K991646,20 Jul2000 I DQX Miraae .008” 1 Micro TheraDeutics I K002212.03 Aua 2000…
Cordis Neurovascular, Inc.1999—
*K002212Mirage Hydrophilic Guidewire, Model 103-0608
Summary page 1
…QX Agility-I 0 I Cordis 1 K991646,20 Jul2000 I DQX Miraae .008” 1 Micro TheraDeutics I K002212.03 Aua 2000 I DQX * This information is assumed based on our best, current knowledge. Cla…
Micro Therapeutics, Inc.2000—
*—PVS 1300 Synchro
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 23, 2024Class IIZ-1909-2024Process designNeurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 4 ancestors has a recall of any class.

How does its category compare?

All DQX devices

DQX Wire, Guide, Catheter: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DQX

10in 2025

2007: 142008: 192009: 182010: 212011: 182012: 202013: 182014: 182015: 152016: 142017: 192018: 192019: 132020: 142021: 62022: 152023: 102024: 112025: 102026 (partial year): 12
2007high 21 (2010) · low 6 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQX

177in 2025

2007: 85 days median2008: 87 days median2009: 87 days median2010: 63 days median2011: 43 days median2012: 62 days median2013: 119 days median2014: 103 days median2015: 112 days median2016: 179 days median2017: 85 days median2018: 114 days median2019: 173 days median2020: 106 days median2021: 161 days median2022: 212 days median2023: 136 days median2024: 134 days median2025: 177 days median2026 (partial year): 145 days median
2007high 212 (2022) · low 43 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQX

3in 2024

2007: 122008: 72009: 492010: 342011: 32012: 52013: 7, 4 Class I2015: 12016: 2, 2 Class I2017: 172018: 92019: 22020: 1, 1 Class I2024: 32026 (partial year): 4, 1 Class I
2007high 49 (2009) · low 0 (2014)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · DQX

2,178in 2025

2007: 7602008: 7152009: 6872010: 9872011: 1,3112012: 1,3372013: 1,4742014: 1,3232015: 1,3232016: 1,4662017: 1,5242018: 1,7372019: 1,6792020: 1,5362021: 1,7132022: 1,6472023: 2,0682024: 2,2102025: 2,178
2007high 2,210 (2024) · low 687 (2009)2025

MAUDE reports naming product code DQX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007148512760
200819877715
2009188749687
2010216334987
2011184331,311
2012206251,337
2013181197 (4)1,474
20141810301,323
20151511211,323
2016141792 (2)1,466
20171985171,524
20181911491,737
20191317321,679
2020141061 (1)1,536
2021616101,713
20221521201,647
20231013602,068
20241113432,210
20251017702,178
2026121454 (1)—

What is it indicated for?

The PVS 1600 Synchro@ 0.010" Neuro Guidewire series of products is intended for neurovascular use. It can be used to selectively introduce and position catheters and other interventional devices within the neurovasculature. This device should be used only by physicians trained in percutaneous, intravascular techniques and procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K023700: PVS 1600 Synchro 0.010 Neuro Guide Wire.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K023700

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026